Systemic anti cancer therapies: Developments in current care

Join us for a hybrid event discussing developments in current care provisions for systemic anti cancer therapies (SACT)

This study day will offer the opportunity to discuss all things associated with systemic anti cancer therapy (SACT) when considering developments in current care provisions. We welcome subject matter experts to share the most up to date information and guidance, as well as highlighting new treatments, and reflect on accessibility to services.

This will be a thought-provoking day which aims to inspire, challenge and direct future clinical care for health professionals.

Thursday 13 February 2025, 9am to 5pm GMT

What to expect

SACT and the current landscape
Cancer and social exclusion: treatment access
Occupational exposure and PPE
Hypersensitivity guidance updates
Extravasation guidance updates
Demystifying immunotherapies: Current developments
A patient-lived experience through SACT

Intended audience

Qualified health care professionals involved in the care of patients having SACT or anyone with a special interest in this patient group, especially nursing and pharmacy staff.

Prices

Early bird - virtual and on-demand: £65
Early bird - onsite (including lunch): £65
Virtual (5 for 4 offer): £64 each
Onsite (5 for 4 offer): £64 each
Student/charity - virtual and on-demand: £50
LMIC countries - virtual and on-demand: £40
Pharma and industry - virtual and on-demand: £159.54 incl. £9.54 fee
Full price - virtual and on-demand: £80
Full price - onsite (including lunch): £80

All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.